IHC from the patients tumor showed lack of MLH1 expression and a common polymorphisms in MLH1 was identified in this patient with Sanger sequencing during mutation screening (MLH1 c.655A>G, p.Ile219Val – classified as class 1 in LOVD). The gene discussed is MLH1; the disease is neoplasm.